Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. [electronic resource]
Producer: 20080410Description: 720-8 p. digitalISSN:- 1524-4571
- Angiotensin II -- administration & dosage
- Animals
- Aorta -- enzymology
- Blood Pressure
- Calcium-Binding Proteins -- genetics
- Calpain -- antagonists & inhibitors
- Cysteine Proteinase Inhibitors -- genetics
- Disease Models, Animal
- Fibrosis
- Genetic Therapy -- methods
- Hypertension -- chemically induced
- Hypertrophy
- Hypertrophy, Left Ventricular -- etiology
- Inflammation -- etiology
- Infusion Pumps, Implantable
- Mice
- Mice, Transgenic
- Muscle, Smooth, Vascular -- metabolism
- Myocardium -- enzymology
- NF-kappa B -- metabolism
- NFATC Transcription Factors -- metabolism
- Renal Artery -- enzymology
- Time Factors
- Ventricular Remodeling
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.